IKT - Inhibikase Therapeutics Inc. (IKT) CEO Milton Werner on Q1 2022 Results - Earnings Call Transcript
Inhibikase Therapeutics, Inc. (IKT) Q1 2022 Earnings Conference Call May 17, 2022 08:00 AM ET Company Participants Alex Lobo - Stern Investor Relations Milton Werner - Chief Executive Officer Joseph Frattaroli - Chief Financial Officer Conference Call Participants Presentation Operator Greetings, welcome to Inhibikase Therapeutics’ First Quarter 2022 Financial Results Conference Call. At this time, all participants are in listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] Please note this conference is being recorded. I will now turn the conference over to Alex Lobo, Stern Investor Relations. Thank you. You may now begin. Alex Lobo Thank you, Sherry. Good morning and welcome to Inhibikase Therapeutics first quarter 2022 financial results conference call and audio webcast. With me today is Dr. Milton Werner, Chief Executive Officer; and Joseph Frattaroli, Chief Financial Officer. Yesterday afternoon Inhibikase issued a press release announcing financial results for the first quarter ended
For further details see:
Inhibikase Therapeutics, Inc. (IKT) CEO Milton Werner on Q1 2022 Results - Earnings Call Transcript